Genetic mutation linked to rare heart muscle disease: Study

Image
ANI Washington D.C. [USA]
Last Updated : Nov 15 2016 | 3:42 PM IST

A recent study, published this in the Journal of the American College of Cardiology, found that genetic mutation and a rare kind of heart muscle disease are associated with each other.

The finding discovered by researchers at the University of Colorado Anschutz Medical Campus could improve understanding of the disease and lead to new treatments.

"There are many kinds of cardiomyopathies that can lead to heart failure so this is a serious problem," said Teisha J. Rowland, a post-doctoral fellow in the lab of Luisa Mestroni, and Matthew R. G. Taylor, MD, PhD, at the University of Colorado School of Medicine and first author of the study.

The Mestroni and Taylor lab sequenced nearly 5,000 genes in 335 patients with a family history of heart muscle disease, looking for mutations that could cause a variety of cardiomyopathies.

"Many kinds of heart disease are caused by genetics. When that happens, the disease is often more severe and happens at an earlier age," said Rowland, who studies genetics and cardiology. "So we look at the DNA in entire families to see what sort of genetic variants those with the illness have in common."

They found that several people with left ventricular noncompaction (LVNC) had a mutation in a gene called Obscurin. Obscurin is part of the sarcomere, the basic unit of striated muscles that pull and glide past each other when muscles contract. That includes the heart muscle. If there is a mutation in Obscurin that process may not function properly.

"We found a strong association between this gene, which has not been studied much, and this rare form of genetic heart disease," Rowland said. "Left ventricular noncompaction is thought to happen during early human development. It would be interesting to see if mutated Obscurin affects heart formation during development."

Rowland said the findings point to areas warranting further attention.

"We expect this will ultimately improve our understanding of the disease," she said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 15 2016 | 3:22 PM IST

Next Story